Atlas Trials

A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

Clinical trial NCT06354998 · COMPLETED

Trial details

NCT number
NCT06354998
Sponsor
ModernaTX, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SARS-CoV-2
Start date
2024-04-08
Primary completion
2024-05-10
Enrollment
217

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.